WMA
ROIV icon

West Michigan Advisors’s Roivant Sciences ROIV Stock Holding History

West Michigan Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,596
Closed -$792K – 341
2026
Q1 		$792K Sell
28,596
-483
-2% -$12.4K 0.17% 135
2025
Q4 		$631K Buy
+29,079
New +$574K 0.14% 141

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

West Michigan Advisors's ROIV Position: Q2 2026 in Review

West Michigan Advisors sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 28,596 shares — an estimated $792K sold.

West Michigan Advisors first reported a position in ROIV in Q4 2025 and held it in 2 quarters. The position peaked at $792K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • West Michigan Advisors reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
  • West Michigan Advisors sold 28,596 Roivant Sciences shares in Q2 2026, an estimated $792K.
  • West Michigan Advisors first reported a position in Roivant Sciences in Q4 2025 and held it in 2 quarters.
  • West Michigan Advisors's Roivant Sciences position peaked at $792K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on West Michigan Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.